Merlin Biotech Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Seed
  • (In Progress)

  • Latest Deal Amount
  • $10M

  • Investors
  • 6

Merlin Biotech General Information

Description

Developer of cancer immune modulators designed to treat adult and pediatric cancers. The company offers mRNA-encoded therapeutics delivered directly to tumors targeting immune pathways, enabling healthcare providers to improve treatment precision and enhance patient outcomes.

Contact Information

Website
www.merlinbiotech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3805 Old Easton Road
  • Doylestown, PA 18902
  • United States
+1 (215)
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 3805 Old Easton Road
  • Doylestown, PA 18902
  • United States
+1 (215)

Merlin Biotech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Merlin Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Seed Round 03-Mar-2026 $10M In Progress Generating Revenue
8. Seed Round 09-Dec-2025 Completed Pre-Clinical Trials
7. Grant 22-Sep-2025 Completed Generating Revenue
6. Seed Round 23-Aug-2024 Completed Pre-Clinical Trials
5. Grant 01-Sep-2023 Completed Generating Revenue
4. Seed Round 30-Aug-2023 Completed Pre-Clinical Trials
3. Accelerator/Incubator 30-Jan-2023 Completed Generating Revenue
2. Grant 28-Nov-2022 $650K Completed Generating Revenue
1. University Spin-Out 01-Jan-2022 Completed Generating Revenue
To view Merlin Biotech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Merlin Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cancer immune modulators designed to treat adult and pediatric cancers. The company offers mRNA-encoded the
Biotechnology
Doylestown, PA
4 As of 2026

San Francisco, CA
 

Carrollton, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Merlin Biotech Competitors (5)

One of Merlin Biotech’s 5 competitors is Siren Biotechnology, a Venture Capital-Backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Siren Biotechnology Venture Capital-Backed San Francisco, CA
Gradalis Private Equity-Backed Carrollton, TX
CancerVAX Venture Capital-Backed Lehi, UT
MiNK Therapeutics Corporation New York, NY
University of Florida Corporation Gainesville, FL
You’re viewing 5 of 5 competitors. Get the full list »

Merlin Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Merlin Biotech Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
U.S. Department of Health and Human Services Government
Angel (individual) Minority
Academic Innovations Holding Corporation
Angel (individual) Minority
Startup Bucks Accelerator/Incubator
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Merlin Biotech FAQs

  • When was Merlin Biotech founded?

    Merlin Biotech was founded in 2022.

  • Where is Merlin Biotech headquartered?

    Merlin Biotech is headquartered in Doylestown, PA.

  • What is the size of Merlin Biotech?

    Merlin Biotech has 4 total employees.

  • What industry is Merlin Biotech in?

    Merlin Biotech’s primary industry is Biotechnology.

  • Is Merlin Biotech a private or public company?

    Merlin Biotech is a Private company.

  • What is Merlin Biotech’s current revenue?

    The current revenue for Merlin Biotech is .

  • How much funding has Merlin Biotech raised over time?

    Merlin Biotech has raised $715K.

  • Who are Merlin Biotech’s investors?

    U.S. Department of Health and Human Services, , Academic Innovations Holding, , and Startup Bucks are 5 of 6 investors who have invested in Merlin Biotech.

  • Who are Merlin Biotech’s competitors?

    Siren Biotechnology, Gradalis, CancerVAX, MiNK Therapeutics, and University of Florida are competitors of Merlin Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process